Chief Medical Officer, Johnson & Johnson
- Development Committee
Joanne Waldstreicher, M.D., is Chief Medical Officer, Johnson & Johnson. In this role, Dr. Waldstreicher has oversight across pharmaceuticals, devices and consumer products for safety, epidemiology, clinical and regulatory operations, and development of the corporate ethical science, technology and R&D policies, including those related to clinical trial transparency and compassionate access. She also chairs the Pharmaceuticals (Janssen) R&D Development Committee and supports the Device and Consumer Development Committees, which review late stage development programs in the pipeline. Dr. Waldstreicher also holds an appointment as a Faculty Affiliate of the Division of Medical Ethics, Department of Population Health, New York University School of Medicine.
Among her prior roles in Janssen, the pharmaceutical sector of Johnson & Johnson, Dr. Waldstreicher was responsible for late-stage development spanning the areas of neuroscience, cardiovascular and metabolism including Invokana®, Xarelto®, Invega Sustenna®, and Invega Trinza®. Before joining Johnson & Johnson in 2002, Dr. Waldstreicher was head of the Endocrinology and Metabolism clinical research group at Merck Research Laboratories, and responsible for overseeing clinical development of Mevacor®, Zocor®, Proscar® and Propecia®, and for clinical development programs in atherosclerosis, obesity, diabetes, urology and dermatology. During that time, she received numerous awards and distinctions, including the Merck Research Laboratory Key Innovator Award.
Dr. Waldstreicher received both the Jonas Salk and Belle Zeller scholarships from the City University of New York and graduated Summa Cum Laude from Brooklyn College. Dr. Waldstreicher graduated Cum Laude from Harvard Medical School in 1987, and completed her internship and residency at Beth Israel Hospital, and her endocrinology fellowship at Massachusetts General Hospital. She has won numerous awards and scholarships, and has authored numerous papers and abstracts. Dr. Waldstreicher combines broad experience in science and medicine along with a passion for advancing transparency and ethics.